News & Updates
Filter by Specialty:
IBD patients see improvements after surgical intervention
A surgical intervention performed for inflammatory bowel disease (IBD) appears to confer favourable effects on patient-reported outcomes such as pain and overall health, according to a prospective, longitudinal cohort study.
IBD patients see improvements after surgical intervention
15 Feb 2024
Immunotherapy, TACE-based regimen may reshape HCC treatment landscape
In the EMERALD-1 trial, durvalumab plus bevacizumab (D+B) combined with transarterial chemoembolization (TACE) improved progression-free survival (PFS) in individuals with unresectable hepatocellular carcinoma (HCC) eligible for embolization.
Immunotherapy, TACE-based regimen may reshape HCC treatment landscape
13 Feb 2024
Folic acid may induce toxicities in capecitabine-treated CRC patients
The presence of folic acid in plasma and intake of folic acid supplements appear to contribute to chemotherapy-induced toxicities in patients treated with capecitabine for colorectal cancer (CRC), reports a recent study.
Folic acid may induce toxicities in capecitabine-treated CRC patients
09 Feb 2024
High diet quality in early life may help prevent IBD later
A high diet quality characterized by increased intake of fish and vegetables and limited consumption of sugary drinks at 1 year of age appears to offer protection against subsequent inflammatory bowel disease (IBD), as reported in a study.